Breaks Categories: News

ThursdayMay 07, 2026 11:43 am

NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Expands Concierge Cardiology Footprint With Atelier Health Agreement

HeartBeam (NASDAQ: BEAT), a medical technology company focused on cardiac care solutions, announced a commercial agreement with Beverly Hills-based concierge medical practice Atelier Health, expanding the company’s launch footprint into Southern California and completing its initial targeted markets alongside New York metro, Dallas and South Florida as it advances commercialization of its cable-free 3D ECG technology for remote cardiac monitoring and preventive cardiology. To view the full press release, visit https://nnw.fm/Itebj About HeartBeam, Inc. HeartBeam, Inc. (NASDAQ: BEAT) is a medical technology company dedicated to transforming the detection and monitoring of critical cardiac conditions. The Company is creating the first-ever cable-free device capable of collecting…

Continue Reading

ThursdayMay 07, 2026 11:32 am

NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Receives FDA Clearance for Depression and Suicidality Trial 

NRx Pharmaceuticals (NASDAQ: NRXP) announced that the U.S. Food and Drug Administration cleared the company to initiate a Phase 2/3 clinical trial evaluating NRX-101 in patients with treatment-resistant major depressive disorder and suicidality receiving active or sham transcranial magnetic stimulation, with the study to be conducted by subsidiary NRx Defense Systems and expected to enroll 240 participants across academic, HOPE Therapeutics and military treatment facility sites. To view the full press release, visit https://nnw.fm/8LXzm About NRx Pharmaceuticals, Inc. NRx Pharmaceuticals, Inc. (www.nrxpharma.com), is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders,…

Continue Reading

ThursdayMay 07, 2026 10:20 am

NetworkNewsBreaks – Nightfood Holdings (OTCQB: NGTF) Spotlighted in AINewsWire Coverage of Expanding Service Robotics Market

Nightfood Holdings (OTCQB: NGTF) announced its inclusion in an editorial published by AINewsWire examining the accelerating adoption of service robotics across industries including healthcare, logistics and hospitality, highlighting the company’s focus on scalable AI-driven robotics systems and strategic collaborations as global demand for automation continues to expand. To view the full press release, visit https://nnw.fm/6yqO6 About TechForce Robotics TechForce Robotics, Inc., a wholly owned subsidiary of the Company, is an AI-Enhanced service-robotics and automation company focused on developing, deploying, and scaling autonomous robotic solutions for hospitality, foodservice, and commercial applications. Through a vertically integrated platform that combines proprietary robotics technology,…

Continue Reading

ThursdayMay 07, 2026 10:00 am

NetworkNewsBreaks – Perpetuals.com Ltd (NASDAQ: PDC) Files Patent Application for BayesShield AI Decision Routing System 

Perpetuals.com (NASDAQ: PDC), an AI-powered fintech company, announced the filing of a U.S. patent application for BayesShield AI, a system designed to identify in real time which AI model or human expert is best suited for a specific decision, with applications across industries including finance, cybersecurity, healthcare and legal analysis, as the company seeks to address reliability and risk-control challenges limiting enterprise adoption of agentic AI systems. To view the full press release, visit https://nnw.fm/Ac6lN About Perpetuals Perpetuals.com Ltd (NASDAQ: PDC) is a fintech company developing AI-powered trading products and prediction markets, with a global footprint across the United States,…

Continue Reading

ThursdayMay 07, 2026 9:50 am

NetworkNewsBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Launches Enterprise Automation Division to Expand AI and Robotics Platform

Nightfood Holdings (OTCQB: NGTF), operating as TechForce Robotics, announced the launch of its Enterprise Automation Division, expanding beyond its Robotics-as-a-Service platform into enterprise-scale automation solutions including system design, engineering, integration and deployment, as the company advances a multi-division growth strategy focused on artificial intelligence, robotics and automation across industries including hospitality, healthcare, logistics and advanced manufacturing. To view the full press release, visit https://nnw.fm/XPaAf About TechForce Robotics TechForce Robotics, Inc., a wholly owned subsidiary of the Company, is an AI-Enhanced service-robotics and automation company focused on developing, deploying, and scaling autonomous robotic solutions for hospitality, foodservice, and commercial applications. Through…

Continue Reading

ThursdayMay 07, 2026 9:34 am

NetworkNewsBreaks – Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) Welcomes Alaska Land Transfer Supporting Ambler District Development 

This article has been disseminated on behalf of Trilogy Metals Inc.  and may include paid advertising.  Trilogy Metals (NYSE American: TMQ) (TSX: TMQ) welcomed the U.S. Department of the Interior’s decision to transfer approximately 1.4 million acres of federal land within Alaska’s Dalton Utility Corridor to the State of Alaska, a move the company said could support infrastructure development, including the proposed Ambler Road project, and help advance critical mineral exploration and development in the Ambler Mining District. To view the full press release, visit https://nnw.fm/Gquk6 About Trilogy Metals Trilogy Metals Inc. is a metal exploration and development company holding a 50 percent interest in Ambler Metals LLC, which has…

Continue Reading

WednesdayMay 06, 2026 12:34 pm

NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Completes $12.5M N2B Asset Transfer to Lunai Bioworks 

Oncotelic Therapeutics (OTCQB: OTLC) announced the consummation of a strategic asset transfer agreement with Lunai Bioworks, Inc., granting worldwide rights to its nose-to-brain (N2B) delivery system IP within biodefense and Alzheimer’s disease fields in exchange for $12.5 million in Series B convertible preferred stock. The agreement establishes an initiative focused on CNS-targeted therapeutics while supporting the company’s strategy to monetize its portfolio and retain control of core assets. The N2B platform enables intranasal delivery directly to the central nervous system, bypassing the blood-brain barrier to support rapid therapeutic action and targeted neurological engagement, with applications in biodefense medical countermeasures and neurodegenerative conditions. Under the agreement, Lunai Bioworks will develop the platform…

Continue Reading

WednesdayMay 06, 2026 12:23 pm

NetworkNewsBreaks – BioAdaptives, Inc. (OTC: BDPT) Launches MyndRenew Nighttime Supplement for Cognitive Recovery 

BioAdaptives (OTC: BDPT) announced the launch of MyndRenew(TM), a nighttime dietary supplement designed to support sleep quality and the brain’s overnight recovery processes, addressing what the company describes as a critical gap in cognitive health as more than one-third of U.S. adults report insufficient sleep. MyndRenew(TM) is part of the MyndSystem(TM) platform, which targets full 24-hour cognitive support, with formulations tailored to both daytime performance and nighttime recovery. The formulation includes 13 ingredients selected from published scientific literature, including magnesium glycinate, apigenin, PEA and lion’s mane mushroom extract, aimed at supporting sleep pathways, cellular repair, stress regulation and neuroprotection. MyndRenew(TM) complements the company’s daytime product, MyndMed(TM), with both products positioned to…

Continue Reading

WednesdayMay 06, 2026 12:12 pm

NetworkNewsBreaks – VolitionRx Ltd. (NYSE American: VNRX) Reports High Accuracy In Feline Cancer Blood Test Study

VolitionRx Limited (NYSE American: VNRX) announced submission for peer review of a clinical manuscript demonstrating the high accuracy of its Nu.Q Vet Feline prototype assay in detecting lymphoma in cats, achieving 97% specificity and identifying 86% of cases, advancing development of a blood-based liquid biopsy test for feline cancer. The company said the technology addresses a significant unmet need in veterinary medicine and represents a commercial opportunity, with potential milestone payments and future revenue generation, as it works toward product commercialization and expands its presence in the growing companion animal oncology market. The publication of this study in a peer reviewed journal is expected subsequently to unlock a $5…

Continue Reading

WednesdayMay 06, 2026 11:49 am

NetworkNewsBreaks – Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) (FSE: T23) Secures Option to Acquire 100% Interest in Hopkins Rare Earths Project 

This article has been disseminated on behalf of Powermax Minerals Inc.  and may include paid advertising.  Powermax Minerals (CSE: PMAX) (OTCQB: PWMXF) (FSE: T23) has entered into an option agreement to acquire a 100% interest in the 5,900-hectare Hopkins Rare Earths Project in northern Ontario, subject to a 2% net smelter returns royalty. The project is situated within the Clay-Howells Alkalic Rock Complex and hosts geological features considered prospective for carbonatite-associated rare earth mineralization, aligning with the company’s strategy to expand its REE-focused exploration portfolio across North America. Figure 1: Geological Map of the Property Area To view the full press release, visit https://nnw.fm/1b6PO About Powermax Minerals Inc. Powermax Minerals Inc.…

Continue Reading